Andrew L Feldman
Overview
Explore the profile of Andrew L Feldman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
209
Citations
6390
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kleinstern G, Robinson D, Rimsza L, Larson M, King R, Nowakowski G, et al.
Cancer Epidemiol Biomarkers Prev
. 2025 Mar;
PMID: 40047811
Background: Diffuse large B-cell lymphoma (DLBCL) is clinically heterogeneous, and gene expression profiling has identified at least two biologically distinct DLBCL subtypes defined by their cell-of-origin (COO): germinal center B-cell...
2.
Guenzel R, Breen W, Go R, Feldman A, Lester S
Adv Radiat Oncol
. 2025 Feb;
10(3):101710.
PMID: 39897384
No abstract available.
3.
Zhu Y, Wong J, Hilal T, Maguire A, Ocal J, Zellner K, et al.
medRxiv
. 2024 Dec;
PMID: 39677423
Primary central nervous system lymphoma (PCNSL) is clinically challenging due to its location and small biopsy size, leading to a lack of comprehensive molecular and biologic description. We previously demonstrated...
4.
Morrow W, Milligan N, Ohgami R, Young K, Wang B, Vega F, et al.
J Hematop
. 2024 Nov;
17(4):215-222.
PMID: 39549220
Anaplastic large cell lymphoma with primary presentation in, and disease limited to, the central nervous system (primary CNS ALCL) is a rare and aggressive lymphoma found in a sensitive anatomic...
5.
Amador C, Weisenburger D, Gomez A, Bouska A, Alshomrani A, Sharma S, et al.
Mod Pathol
. 2024 Nov;
38(2):100646.
PMID: 39491745
Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of neoplasms, with many cases remaining unclassifiable and categorized as PTCL-not otherwise specified (PTCL-NOS). Gene expression profiling (GEP) has delineated 2 prognostic...
6.
Atallah-Yunes S, Rees M, Mwangi R, Kuchler R, Nowakowski G, Habermann T, et al.
Am J Hematol
. 2024 Oct;
100(1):158-162.
PMID: 39400430
Differences in characteristics and outcomes between incidental and symptomatic presentations of Large B-Cell Lymphoma.
7.
Bommier C, Link B, Gysbers B, Maurer M, Larson M, Khurana A, et al.
Blood Adv
. 2024 Sep;
8(23):5939-5948.
PMID: 39321424
Marginal zone lymphoma (MZL) includes extranodal MZL (EMZL), splenic MZL (SMZL), and nodal MZL (NMZL) subtypes. Histologic transformation (HT) to large B-cell lymphomas is well documented but with a large...
8.
Abro B, Maurer M, Habermann T, Burack W, Chapman J, Cohen J, et al.
Blood
. 2024 Sep;
144(19):2063-2066.
PMID: 39255410
Recent introduction of 2 different lymphoma classifications has raised concerns about consistency in diagnosis, management, and clinical trial enrollment. Data from a large cohort reflecting real-world clinical practice suggest that...
9.
Ahmed R, Feldman A
J Hematop
. 2024 Jul;
17(3):179-182.
PMID: 38977645
A 51-year-old female with menorrhagia was found to have a cervical polyp. Polypectomy and endometrial curettage showed an atypical lymphoid infiltrate. Hysterectomy was performed, showing extensive myometrial infiltration by small,...
10.